COHERUS BIOSCIEN.DL-,0001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 8C5 for the last quarter is 63.57 M EUR, and it's 4.78% higher compared to the previous quarter. The net income of Q3 24 is -9.66 M EUR.